2 hedge funds and family offices disclose a GXO position in their latest SEC 13F filing — combined $65.5M in market value.
| # | Investor | Fund | Shares | Value | % of Portfolio | Filed |
|---|---|---|---|---|---|---|
| 1 | Engaged Capital | Engaged Capital LLC | 829,769 | $43.7M | 11.14% | 2025-12-31 |
| 2 | Ray Dalio | Bridgewater Associates LP | 430,309 | $21.8M | 0.09% | 2026-06-30 |
As of the latest 13F window, 2 tracked superinvestors hold GXO. The largest disclosed position is Engaged Capital at $43.7M (11.1% of portfolio).
13F filings are due 45 days after each quarter end and capture long-equity positions held by U.S. institutional managers with $100M+ AUM. Use this page to see exactly who is buying GXO, how concentrated each position is, and the implied conviction level relative to the rest of each investor's book.
Key takeaways
2 hedge funds and family offices disclose a GXO position in their latest SEC 13F filing — combined $65.5M in market value.
| # | Investor | Fund | Shares | Value | % of Portfolio | Filed |
|---|---|---|---|---|---|---|
| 1 | Engaged Capital | Engaged Capital LLC | 829,769 | $43.7M | 11.14% | 2025-12-31 |
| 2 | Ray Dalio | Bridgewater Associates LP | 430,309 | $21.8M | 0.09% | 2026-06-30 |
As of the latest 13F window, 2 tracked superinvestors hold GXO. The largest disclosed position is Engaged Capital at $43.7M (11.1% of portfolio).
13F filings are due 45 days after each quarter end and capture long-equity positions held by U.S. institutional managers with $100M+ AUM. Use this page to see exactly who is buying GXO, how concentrated each position is, and the implied conviction level relative to the rest of each investor's book.
Key takeaways
